NLRP3 and Parkinson disease: Particularly in the LPS-induced PD mouse brain model, Ka promoted the ubiquitination modification of the NLRP3 protein, thereby preventing its activation, reducing NLRP3 inflammasome expression, and slowing neuroinflammation and neuronal damage caused by overproduction of IL-1β [67].